Horseweed (Canadian fleabane, Conyza Canadensis, Erigeron Canadensis, Fleabane, Hogweed)
Suggested dosing of Canadian fleabane, Conyza Canadensis (horseweed)
Follow Mfr's protocoL
Suggested uses of Canadian fleabane, Conyza Canadensis (horseweed)
Bleeding, diarrhea (dysentery), water retention
Canadian fleabane, Conyza Canadensis (horseweed) adverse (side) effects
Contact dermatitis
Warnings
Cautions
Contact dermatitis
Pregnancy and lactation
Pregnancy category: N/A
Lactation: N/A
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Canadian fleabane, Conyza Canadensis (horseweed)
Metabolism: N/A
Excretion: N/A
Mechanism of action
Tannin: diuretic and hemostatic effect
